≥99% HPLCPre-filled pen

TB4 (Thymosin Beta 4)

Name: TB4 (Thymosin Beta 4)
Brand: Dripfy
Availability: InStock

What it is?

TB4 (Thymosin Beta 4) is a naturally occurring peptide associated with tissue protection and regeneration signalling. It is studied for its role in cell migration, tissue remodelling, and repair microenvironments, and is often positioned for recovery- and resilience-focused protocols.

Dripfy Advantage

Cell migration & regeneration: Supports cellular migration pathways that contribute to tissue re-organisation and repair.
Tissue remodelling dynamics: Positioned to support extracellular matrix remodelling and structural recovery processes.
Inflammation and fibrosis interface: Associated with modulation of inflammation signalling and fibrosis-related pathways during healing cycles.
System-level resilience: Often positioned for broader recovery stacks where multi-tissue resilience and repair signalling are desired.

Clinical Applications & Therapeutic Potential

Wound healing and tissue repair: Positioned for enhanced repair signalling and tissue restoration endpoints.
Sports injury recovery: Potential support for recovery kinetics and mobility restoration markers following training-related microtrauma.
Inflammation/fibrosis modulation: Potential support for reduced fibrosis-associated signalling and improved tissue quality outcomes.
Cardiovascular-protective signalling (research context): Frequently studied in relation to vascular and tissue-protection pathways relevant to cardiovascular integrity markers.

Composition & Formulation

Peptide Content: 5 mg TB-500
Vehicle: Proprietary pH-balanced buffer solution
Delivery System: Pre-filled, multi-dose, closed-system pen
Total Volume: 3 mL
Purity: ≥99% by HPLC/MS

€534

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Pre-filled pen
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

TB4 (Thymosin Beta 4)

Investigational Thymosin Beta-4 peptide (regenerative / cytoprotective) · Pre-filled pen

D· Preliminary evidence

TB4 is the naturally occurring peptide Thymosin Beta-4, a regulator of actin dynamics within cells. Preclinical work links it to cell migration, tissue remodelling, angiogenesis and the modulation of inflammation and fibrosis during healing. Human evidence is early-stage, so its role in recovery is studied rather than established.

Studied use areas

Wound-healing signalling (research context)
Tissue protection and regeneration
Cell migration during repair
Fibrosis and inflammation interface during healing
Multi-tissue recovery frameworks

Safety & status

Investigational and not an approved medicine; human safety data are early-stage and limited
Prohibited in competitive sport under the WADA prohibited list
Use only under qualified physician oversight with appropriate screening

⚕ Clinical note: This card is educational and is not medical advice. TB4 is investigational; any use must be individualised and supervised by the treating physician.

Evidence: Investigational — early-stage human data, mainly preclinical; no approved human indication · References: peer-reviewed regenerative-medicine and preclinical tissue-repair literature; EMA/MHRA regulatory-status information on unapproved peptides; sports anti-doping (WADA) prohibited-substance listings